Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 312.50 | 129.17 | 386.00 | 204.75 | 1.8852 | 4.1921 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 312.50 | 129.17 | 245.00 | 204.75 | 1.1966 | 1.6200 |
| BT-20 | 17-AAG | 0.0001 | uM | 8 | 312.50 | 129.17 | 302.00 | 204.75 | 1.4750 | 2.5891 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 298.00 | 204.75 | 1.4554 | 2.5178 | |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 312.50 | 129.17 | 272.00 | 204.75 | 1.3284 | 2.0663 |
| BT-20 | Erlotinib | 10 | uM | 8 | 312.50 | 129.17 | 200.00 | 204.75 | 0.9768 | 0.9306 |
| BT-20 | 17-AAG | 0.001 | uM | 8 | 312.50 | 129.17 | 284.00 | 204.75 | 1.3871 | 2.2721 |
| BT-20 | Lapatinib | 10 | uM | 8 | 312.50 | 129.17 | 113.00 | 204.75 | 0.5519 | -0.1822 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 182.00 | 204.75 | 0.8889 | 0.6752 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 186.00 | 204.75 | 0.9084 | 0.7309 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 312.50 | 129.17 | 203.00 | 204.75 | 0.9915 | 0.9743 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 142.00 | 204.75 | 0.6935 | 0.1532 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 182.00 | 204.75 | 0.8889 | 0.6752 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 174.00 | 204.75 | 0.8498 | 0.5656 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 248.00 | 204.75 | 1.2112 | 1.6684 | |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 312.50 | 129.17 | 242.00 | 204.75 | 1.1819 | 1.5719 |
| BT-20 | Erlotinib | 3.1623 | uM | 8 | 312.50 | 129.17 | 156.00 | 204.75 | 0.7619 | 0.3284 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 312.50 | 129.17 | 111.00 | 204.75 | 0.5421 | -0.2039 |
| BT-20 | Linsitinib | 19.9526 | uM | 8 | 312.50 | 129.17 | 174.00 | 204.75 | 0.8498 | 0.5656 |
| BT-20 | Linsitinib | 0.01 | uM | 8 | 312.50 | 129.17 | 300.00 | 204.75 | 1.4652 | 2.5534 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 312.50 | 129.17 | 251.00 | 204.75 | 1.2259 | 1.7171 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 312.50 | 129.17 | 285.00 | 204.75 | 1.3919 | 2.2894 |
| BT-20 | 17-AAG | 0.031623 | uM | 8 | 312.50 | 129.17 | 104.00 | 204.75 | 0.5079 | -0.2782 |
| BT-20 | Lapatinib | 0.1 | uM | 8 | 312.50 | 129.17 | 311.00 | 204.75 | 1.5189 | 2.7512 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 312.50 | 129.17 | 254.00 | 204.75 | 1.2405 | 1.7661 |